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Objective: To determine the incidence and associated factors of multidrug-resistant hospital-
associated infections (MDR-HAI) in a pediatric intensive care unit (PICU) of a university hospital in
Thailand.
Method: A prospective study was performed in the PICU of King Chulalongkorn Memorial Hospital
during the period May—December 2005. Children aged 15 years who developed a PICU-related
HAI were studied.
Results: Forty-four patients (median age 6 months; male:female = 1.4:1) developed 58 episodes
of PICU-related HAI. The HAI rate was 28.3 per 1000 patient-days. Thirty episodes (52%) were
MDR-HAI. The following were found more frequently in MDR-HAI when compared to non-MDR-HAI:
Acinetobacter baumannii (50% vs. 23%, p = 0.04), female sex (60% vs. 29%, p = 0.02), admission to
the PICU with amedical condition (90% vs. 64%, p = 0.03), PICU stay longer than 7 days prior to the
development of HAI (67% vs. 36%, p = 0.03), and previous use of broad-spectrum antibiotics (83%
vs. 43%, p = 0.002). Independent risk factors for MDR-HAI included female sex (OR = 5.5, p = 0.03)
and previous use of a broad-spectrum antibiotic (OR = 9.7, p = 0.01).
Conclusion: The incidence of MDR-HAI was high in the PICU. Female sex and previous use of a
broad-spectrum antibiotic were independent risk factors for MDR-HAI.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.* Corresponding author. Tel.: +66 2 256 4951; fax: +66 2 256 4911.
E-mail address: suchadacu@hotmail.com (S. Sritippayawan).
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Multidrug-resistant hospital-associated infections (MDR-HAI)
are increasing worldwide, especially among those who are
admitted to the intensive care unit (ICU), and can be a major
cause of morbidity and mortality in these patients. SeveralPublished by Elsevier Ltd. All rights reserved.
MDR hospital-associated infections in a PICU 507studies have reported the incidence and associated factors of
MDR-HAI in the adult ICU.1—6 However, studies in the pedia-
tric ICU (PICU) are scarce, especially among those in South-
east Asian countries. Most of the studies in pediatrics have
focused on specific HAI and MDR-HAI caused by some specific
etiologic agents.7—12 The incidence, etiologic agents, and
associated factors of MDR-HAI can vary among PICUs and are
important for the development of appropriate HAI control
measures in each patient care setting. We therefore under-
took this study to determine the incidence and associated
factors of MDR-HAI in a PICU of a university hospital in
Thailand.
Patients and methods
Study design and setting
A prospective study was performed on children aged 15
years who were admitted to the PICU of King Chulalongkorn
Memorial Hospital during the period May—December 2005.
The study protocol was approved by the Ethics Committee for
Human Research Study of Chulalongkorn University.
King Chulalongkorn Memorial Hospital is a tertiary-care
university hospital in Thailand. There is one PICU that serves
medical and surgical pediatric patients aged up to 15 years,
except neonates aged less than 72 hours. The PICU setting is a
10-bed unit divided into two five-bed subunits and four
single-patient rooms for immunocompromised patients and
those who have specific infectious diseases that need isola-
tion. The bedside care medical staff consist of one full-time
pediatric pulmonologist who is a PICU attending, one pedia-
tric pulmonary fellow, and four to five pediatric residents.
The nursing staff provide bedside patient care on a one-on-
two basis (one nurse per two patients) during the daytime and
nighttime shifts. Patient care and antibiotic use are decided
by the attending PICU physicians. No authorization from the
infectious disease specialist is required prior to the prescrip-
tion of broad-spectrum antibiotics.
Infection control measures are set and monitored by the
Hospital Associated Infection Control Committee of the hos-
pital. The guidelines are set according to those of the Centers
for Disease Control and Prevention (CDC).13 Hygienic hand
washing with soap and water or alcohol-based hand rub
before and after each patient contact is encouraged for all
healthcare personnel who are working in the PICU and the
family members who come to visit the patients. Alcohol-
based hand rub is provided at the bedside for each bed and at
the entrance to the PICU. There are two hand-washing sinks
per five patient beds and one for each single-patient room.
All healthcare workers are encouraged to use gloves when in
contact with the patient or patient body fluids, secretions,
and excretions. Gowns and goggles are not routinely used
except in situations where there is a risk for body fluid,
secretion, or excretion contamination. The respiratory ther-
apy equipment is cleaned and sterilized according to the CDC
guidelines.14 Ventilator circuit and humidifiers are changed
every 48 hours. Water used for humidifiers and nebulizers is
changed every 8 hours. Small-volume medication nebulizers
are restricted to single-patient use only. No sharing between
patients is allowed unless there has been appropriate rest-
erilization. Following each use in the same patient, they arecleaned with soap and water, and they exchanged with a
sterilized replacement once every day.
Definitions
PICU-related HAI was defined as any infection that was not
present or incubating at the time of PICU admission but
occurred at 48 hours or more after admission to the PICU.15
To calculate the HAI rate, we collected the number of
patients in the PICU and the total number of patient-days
of stay on amonthly basis. The percent of HAI and the number
of HAI per patient-days were calculated by dividing the total
number of PICU-related HAI pooled throughout all themonths
by the total number of PICU patients (100) and patient-days
(1000), respectively.
The specific HAI-type was diagnosed according to the
criteria set by the CDC.16 Device-associated HAI such as
ventilator-associated pneumonia (VAP), catheter-related
bloodstream infection (CR-BSI), and catheter-related urin-
ary tract infection (CR-UTI) were diagnosed if the patient
developed clinical signs and symptoms of pneumonia, blood-
stream infection, and urinary tract infection (as per CDC
criteria), respectively, after being on mechanical ventila-
tion or having the indwelling device for at least 48 hours.
Etiologic agents were identified from cultures obtained from
the related sites suggested by the CDC, except for nosoco-
mial pneumonia where the cultures were obtained from
endotracheal aspirates.
Antimicrobial susceptibility was identified using the
Kirby—Bauer disk diffusion method. We defined MDR-HAI as
any HAI caused by any of the following organisms: (1) Steno-
trophomonas maltophilia (no matter what the antibiotic
susceptibility pattern was); (2) Acinetobacter spp that were
resistant to beta-lactam/beta-lactamase inhibitors, tri-
methoprim—sulfamethoxazole, and at least one from each
of the following antibiotic classes: aminoglycoside, ciproflox-
acin, piperacillin, third-/fourth-generation cephalosporin,
and carbapenem; (3) other aerobic Gram-negative rods
(GNR) including Enterobacteriaceae and Pseudomonas that
were resistant to three or more of the following antibiotic
classes: beta-lactam/beta-lactamase inhibitors (only for
Enterobacteriaceae), at least one aminoglycoside, ciproflox-
acin, piperacillin, third-/fourth-generation cephalosporin,
and carbapenem; (4) methicillin-resistant staphylococci;
(5) vancomycin-resistant enterococci.
Broad-spectrum antibiotics included piperacillin/tazo-
bactam, ceftazidime, cefepime, ciprofloxacin, imipenem/
cilastatin, meropenem, and sulbactam/cefoperazone.
Collected data
During the study period, all patients in the PICU were mon-
itored for HAI. Patients were monitored daily until discharge
from the PICU or death. Collected data included age, gender,
underlying diseases, nutritional status, indication for PICU
admission, referral from another PICU, length of PICU stay
prior to the development of HAI, types of invasive procedures
performed (such as endotracheal intubation, nasogastric
catheterization, central venous catheterization, arterial
catheterization, urinary catheterization, intravenous parent-
eral nutrition), types and duration of stress ulcer prophylaxis,
508 S. Sritippayawan et al.sites of HAI, antibiotics prescribedwithin the last 15 days prior
to the development of HAI, isolated organisms related to HAI
and their antibiotic susceptibility patterns, lengthofPICUstay,
and final outcome of the patients during PICU stay (survived or
died).
Data acquisition and analysis
The patients were divided into two groups, MDR-HAI and
non-MDR-HAI, on the basis of the susceptibility patterns of
the isolated organisms related to the HAI. Continuous
variables were compared between the two groups using
the Student’s t-test or Mann—Whitney U-test where applic-
able. Categorical variables were compared using the Chi-
square test or Fisher’s exact test. Multiple logistic regres-
sion analysis was used to identify the independent
factors associated with MDR-HAI. All potential risk factors
showing a p value of <0.2 in the univariate analysis were
included in the regression model. Odds ratios (OR) and 95%
confidence intervals (95% CI) were calculated. A two-tailed
p-value of <0.05 was considered statistically significant.
The statistical analysis was performed using GraphPad
Instat Program (GraphPad Software Inc., San Diego, CA,
USA) and SPSS version 13.0 for Windows (SPSS Inc., Chi-
cago, IL, USA).
Results
During the study period, 347 patients were admitted to the
PICU. The total patient-days was 2052 days. Forty-four
patients (median age 6 months, range 4 days—14 years;
male:female = 1.4:1) developed 58 episodes of HAI
during their PICU stays. Thirty-four patients (77%)
were aged under 5 years. The HAI rate was 16.7%, equiva-
lent to 28.3 HAI per 1000 patient-days. Among the 58
episodes of PICU-related HAI, 30 episodes (52%) were
caused by MDR organisms (MDR-HAI), while 28 episodes
(48%) were caused by non-MDR organisms (non-MDR-HAI).
Indications for PICU admission were pneumonia with
respiratory failure (51%), post-surgery (22%), sepsis
(21%), and others (6%).Table 1 Isolated organisms related to hospital-associated infect
MDR-HAI (n = 32)
Isolated organisms related to nosocomial infection (%)
Gram-negative rods
Acinetobacter baumannii 16 (50%)
Pseudomonas aeruginosa 5 (16%)
Klebsiella spp 3 (9%)
Enterobacter spp 1 (3%)




Staphylococcus aureus 1 (3%)
Coagulase-negative staphylococci 2 (6%)
Enterococcus spp 2 (6%)
MDR-HAI, multidrug-resistant hospital-associated infection; OR, odds rTypes of HAI
Of the total of 44 patients who developed HAI during their
PICU stay, all were intubated and on a mechanical ventilator
(34 episodes of VAP were observed). Forty-one patients (93%)
had a central venous catheter insertion (11 episodes of CR-BSI
were observed), while 30 patients (68%) had a urinary cathe-
ter placement (five episodes of CR-UTI were observed). Eight
episodes of PICU-related HAI were surgical site infections.
VAP was the most common HAI found in both the MDR-HAI and
non-MDR-HAI groups (67% and 54%, respectively). There was
no statistical difference between the MDR-HAI and non-MDR-
HAI groups with regard to HAI type (data not shown).
Isolated organisms
GNR were the most commonly isolated organisms associated
with PICU-related HAI (48/62 isolations, 77%). Others
included staphylococci (9/62 isolations, 15%) and entero-
cocci (5/62 isolations, 8%). Acinetobacter baumannii was
the most commonly isolated GNR. Sixty-four percent (16/
25 isolations) of Acinetobacter and 58% (7/12 isolations) of
Pseudomonas were MDR. All of them were resistant to car-
bapenem. Among the nine isolated staphylococci, one (11%)
was methicillin-resistant Staphylococcus aureus (MRSA) and
two (22%) were methicillin-resistant coagulase-negative sta-
phylococci. Forty percent of isolated enterococci (2/5 iso-
lations) were vancomycin-resistant (Table 1). A. baumannii
was found more frequently in the MDR-HAI group than in the
non-MDR-HAI group (50% vs. 23%; p = 0.04) (Table 1).
Isolated organisms associated with each
type of HAI
Among 34 episodes of VAP, the most commonly isolated
organism was A. baumannii (16 episodes, 47%). Others
included Pseudomonas aeruginosa (eight episodes), Kleb-
siella pneumoniae (three episodes), other Pseudomonas
spp (three episodes), coagulase-negative staphylococci
(three episodes), enterococci (one episode), Enterobacter
(one episode), and S. aureus (one episode).ions (total number of isolations = 62).
non-MDR-HAI (n = 30) p-Value OR (95% CI)
7 (23%) 0.04 3.3 (1.1—9.8)
4 (13%) 1.0 1.2 (0.3—5.0)
3 (10%) 1.0 0.9 (0.2—5.0)
2 (7%) 0.6 0.5 (0.03—5.3)
1 (3%) 1.0 1.9 (0.2—22.5)
2 (7%) 0.2 0.2 (0.0—3.8)
2 (7%) 0.2 0.2 (0.0—3.8)
0 1.0 2.9 (0.1—74.2)
6 (20%) 0.1 0.3 (0.05—1.4)
3 (10%) 0.7 0.6 (0.1—3.9)
atio; CI, confidence interval.
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most commonly isolated organisms were A. baumannii (four
episodes, 36%) and coagulase-negative staphylococci (four
episodes, 36%). Others included Acinetobacter lwoffii (two
episodes), K. pneumoniae (one episode), and enterococci
(one episode).
In the PICU-related surgical site infection group
(eight episodes), the most commonly isolated organism
was A. baumannii (three episodes, 38%). Others
included enterococci (two episodes), K. pneumoniae
(one episode), P. aeruginosa (one episode), coagulase-
negative staphylococci (one episode), and Escherichia coli
(one episode).
The isolated organisms associated with CR-UTI (five epi-
sodes) were Enterobacter (two episodes, 40%), Enterococcus
(one episode), K. pneumoniae (one episode), and E. coli (one
episode).
There were two episodes of VAP, one episode of CR-BSI,
and one episode of surgical site infection where two organ-
isms were isolated at the same time.Table 2 Comparison of clinical characteristics between the multid
resistant hospital-associated infection groups.
Characteristics MDR-HAI
(n = 30)
Median age (range) 11 months (0.
Female 18 (60)
Male 12 (40)
Malnourished patients 19 (63)
Immunocompromised patients 10 (33)
Referred from other PICU 9 (30)
Indication for PICU admission
Medical conditiona 27 (90)
Post-surgery 3 (10)
Procedures
ETT and mechanical ventilation 30 (100)
Nasogastric catheterization 28 (93)
Central venous catheterization 29 (97)
Urinary catheterization 20 (67)
Intravenous parenteral nutrition 10 (33)
Arterial catheterization 4 (13)
Stress ulcer prophylaxis
PI or H2-blocker 22 (73)
Sucralfate 7 (23)
Duration of PICU days >7 days prior to
the development of HAI
20 (67)
Broad-spectrum antibiotic use within the
last 2 weeks prior to the development of HAI
25 (83)
Mean (SD) total PICU days; (range) 26.2 (18.6); (3
Mortality rate 5 (17)
Results are n (%) unless stated otherwise.
MDR-HAI, multidrug-resistant hospital-associated infection; OR, odds rat
endotracheal intubation; HAI, hospital-associated infection; PI, proton
a Medical conditions included pneumonia, sepsis, shock, and heart faFactors associated with MDR-HAI
Comparison of clinical characteristics between the MDR-HAI
and non-MDR-HAI groups found no difference in age, number
of malnourished patients (body weight less than the third
percentile for age), number of immunocompromised
patients, number of patients referred from another PICU,
exposure to invasive procedures during PICU stay, type of
stress ulcer prophylaxis, mean total PICU stay, and mortality
rate (Table 2). However, A. baumannii (50% vs. 23%,
p = 0.04), female sex (60% vs. 29%, p = 0.02), and admission
to the PICU with medical conditions (such as pneumonia,
sepsis, shock, and heart failure; 90% vs. 64%, p = 0.03) were
found more commonly in the MDR-HAI group when compared
to the non-MDR-HAI group (Tables 1 and 2). Those who had
MDR-HAI had a longer PICU stay prior to the development of
HAI than those who had non-MDR-HAI (14.0  10.7 days vs.
8.6  7.9 days, p = 0.03). PICU stay longer than seven days
prior to the development of HAI was foundmore frequently in
the MDR-HAI group when compared to the non-MDR-HAI grouprug-resistant hospital-associated infection and non-multidrug-
non-MDR-HAI
(n = 28)
p-Value OR (95% CI)
1—168) 4 months (0.3—117) 0.06
8 (29) 0.02 3.7 (1.2—11.2)
20 (71) 0.02 0.5 (0.3—0.9)
20 (71) 0.58 0.7 (0.2—2.1)
6 (21) 0.38 1.8 (0.6—6.0)
9 (32) 1.0 0.9 (0.3—2.8)
18 (64) 0.03 5 (1.2—20.7)
10 (36) 0.03 0.2 (0.1—0.8)
28 (100) - -
27 (96) 1.0 0.5 (0.04—6.1)
26 (93) 0.61 2.2 (0.2—26.1)
20 (71) 0.78 0.8 (0.3—2.4)
8 (29) 0.78 1.2 (0.4—3.8)
6 (21) 0.50 0.6 (0.1—2.3)
17 (61) 0.40 1.8 (0.6—5.4)
2 (7) 0.15 3.9 (0.7—21.0)
10 (36) 0.03 1.9 (1.1—3.3)
12 (43) 0.002 2.8 (1.3—6.3)
—70) 21.2 (13.5); (3—53) 0.26
6 (21) 0.74 0.7 (0.2—2.7)
io; CI, confidence interval; PICU, pediatric intensive care unit; ETT,
pump inhibitor.
ilure.
Table 3 Summary of logistic regression analysis to identify independent risk factors for multidrug-resistant hospital-associated
infection in the pediatric intensive care unit (all potential risk factors showing a p value of <0.2 in the univariate analysis were
included in the regression model).
Variables OR 95% CI p-Value
Acinetobacter baumannii 3.9 0.9—16.7 0.07
Female 5.5 1.1—27.1 0.03
Indication for PICU admission
Medical conditiona 1.9 0.3—11.4 0.5
Post surgery 0.5 0.1—3.2 0.5
Use of sucralfate as a stress ulcer prophylaxis 8.5 0.8—91.5 0.08
Duration of PICU stay > 7 days prior to the development of HAI 1.2 0.3—4.9 0.8
Broad-spectrum antibiotic use within the last 2
weeks prior to the development of HAI
9.7 1.8—53.4 0.01
OR, odds ratio; CI, confidence interval; PICU, pediatric intensive care unit; HAI, hospital-associated infection.
a Medical conditions included pneumonia, sepsis, shock, and heart failure.
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trum antibiotic use within 15 days prior to the development
of HAI was found more commonly in the MDR-HAI group than
the non-MDR-HAI group (83% vs. 43%, p = 0.002) (Table 2).
Multiple logistic regression analysis showed that female sex
(OR = 5.5, p = 0.03) and previous use of a broad-spectrum
antibiotic (OR = 9.7, p = 0.01) were independent risk factors
for MDR-HAI (Table 3).
Discussion
The incidence of PICU-related HAI in this study was 16.7%,
equivalent to 28.3 HAI per 1000 patient-days. Fifty-two per-
cent of HAI episodes were caused by MDR organisms. VAP, CR-
BSI, and CR-UTI were common PICU-related HAI, while GNR
and staphylococci were the commonly isolated organisms.
Despite having a different PICU structure and setting when
compared to those in Europe and North America, we found the
same pattern of common HAI and related organisms.17—23
The most commonly isolated organism in this study was A.
baumannii. Acinetobacter are ubiquitous, aerobic Gram-
negative bacilli that prefer a moist environment.24 Patients
who need assisted mechanical ventilation or aerosol therapy
can be exposed to and colonized with this organism. In this
study, A. baumannii was the most commonly isolated organ-
ism among those who developed VAP. It was also the most
commonly isolated organism among those who had a CR-BSI
and surgical site infection during their PICU stay. Several
previous studies have reported Acinetobacter as one of the
predominant organisms isolated from patients in the
PICU.8,9,12 Colonization of the organisms in the moist envir-
onment, especially in the ventilator circuits and humidifier
equipment, in addition to inadequate adherence to infection
control guidelines could have led to cross-contamination
between person to person and environment to person and
a high incidence of Acinetobacter infection in our PICU.
In this study, 64% of isolated Acinetobacter were carba-
penem-resistant. This proportion is comparable to that
recently reported from a PICU in Greece, which found 62%
of imipenem-resistant A. baumannii.25 MDR-Acinetobacter is
an emerging worldwide problem, in both the adult andpediatric ICU. Previous use of broad-spectrum antibiotics
has been reported to be associated with the occurrence of
MDR-Acinetobacter.8,26 Rational use of antibiotics is neces-
sary. However, surveillance of Acinetobacter colonization in
the PICU and effective monitoring of adherence to the HAI
control guidelines are also important. It is well documented
that hand washing is the most effective strategy to prevent
the development and spread of HAI. However, it is perhaps
too simple and easily forgotten, especially during an emer-
gency situation in the PICU. Repeat education and emphasis
on the importance of HAI control for medical personnel as
well as regular monitoring of adherence to the guidelines
should be mandatory.
Besides a high proportion of MDR-Acinetobacter, we also
found a high proportion of MDR-Pseudomonas. Fifty-eight
percent of isolated Pseudomonas in our study were MDR
(Table 1). All of them were imipenem-resistant. This is high
when compared to rates reported in an adult ICU in Thailand
and in an EPIC study, which found 31% and 21%, respectively,
of isolated P. aeruginosa resistant to imipenem.4,27 Prolonged
use of certain antibiotics has been reported as an important
risk factor for MDR-Pseudomonas hospital-associated infec-
tion.2,6 Surveillance of the antimicrobial susceptibility pat-
tern and establishment of a policy for antibiotic prescription
may be helpful in controlling the emergence of resistant
strains.
Most of the isolated staphylococci in our study were
coagulase-negative staphylococci. Only one of the isolated
staphylococci was S. aureus, which was resistant to methi-
cillin. Twenty-two percent of isolated coagulase-negative
staphylococci were resistant to methicillin. This is relatively
low when compared to rates reported in an adult ICU in
Thailand and an EPIC study, which found 44% and 70%,
respectively, of isolated coagulase-negative staphylococci
that were resistant to methicillin,4,27 particularly as we
had a high proportion of patients who had central venous
catheter placement. Previous studies have reported coagu-
lase-negative staphylococci as the most common pathogens
related to hospital-associated bloodstream infec-
tions.4,16,27,28 However, a recent study by Lakshmi et al.
found that GNR, especially K. pneumoniae, were the pre-
dominant organisms isolated among those who developed
MDR hospital-associated infections in a PICU 511primary bloodstream infections in the PICU.11 In our study, we
found that Acinetobacter was one of the two most commonly
isolated organisms among those who had a CR-BSI. The
pathogen responsible for CR-BSI can change over time and
varies among ICUs. It depends not only on the use of central
venous catheters, but also other factors such as type of
bacterial colonization on the skin and in the ICU environ-
ment, previous use of antibiotics (especially broad-spec-
trum), type and severity of the patient illness, patient
care procedures, and adherence to HAI control guidelines.
Several investigators have been trying to identify factors
associated with MDR-HAI. Risk factors that have commonly
been reported include prolonged ICU stay, frequent use of
invasive devices, and severe underlying diseases.2,6—8,26,29,30
Excessive use of antibiotics has been identified as a factor
associated with the emergence of MDR organisms. Some
studies have reported a relationship between the use of a
particular antibiotic and the occurrence of specific drug-
resistant bacteria, such as piperacillin and E. coli, and
third-generation cephalosporins and K. pneumoniae.6,7 In
this study, we found that previous use of a broad-spectrum
antibiotic was one of the independent risk factors for MDR-
HAI in the PICU. This is in agreement with results of previous
studies and correlates with the high incidences of MDR-
Acinetobacter and MDR-Pseudomonas in our PICU. In some
studies, the initiation of antimicrobial control programs has
been reported to increase bacterial antibiotic susceptibility
and decrease resistant bacteria.31—34 Our approach to anti-
microbial prescription needs to be rationalized. An author-
ization system would help in controlling the inappropriate
use of broad-spectrum antibiotics. In addition, regular mon-
itoring of antibiotic susceptibility patterns is also essential.
Guidelines on the prevention of antimicrobial resistance
should be developed and focus largely on appropriate anti-
biotic prescribing.
We also found a higher proportion of females in the MDR-
HAI group. This has not been reported in any previous study.
However, further studies in a larger sample size and over a
longer period of time are needed prior to drawing any con-
clusions relating gender to susceptibility to MDR-HAI.
This study had a limitation in the identification of the
etiologic agents responsible for VAP. Bronchoalveolar lavage
or protected brush biopsy has been recommended as a
diagnostic procedure for identifying the causative agent of
VAP.16 However, there are some technical limitations with
these procedures, especially in small babies. Since most of
our study patients were small (median age 6 months, 77%
aged less than 5 years), we obtained the culture from endo-
tracheal aspirates instead. Even though this is not the gold
standard method for identifying the etiologic agent of VAP, it
is non-invasive and provided some useful information regard-
ing the endotracheal colonization and the selection of an
antibiotic.
In conclusion, we have reported a high incidence of MDR-
HAI in a PICU of a university hospital in Thailand and risk
factors for these infections. Despite having a different PICU
setting, we found the same pattern of common PICU-related
HAI and associated organisms when compared to those
reported in developed countries. However, the incidences
of each isolated organism as well as the incidences of the MDR
strains were different. Several factors mentioned above, as
well as differences in the criteria used for the diagnosis of HAIcould have contributed to the discrepancies in the findings
among the studies. Female sex and previous use of broad-
spectrum antibiotics were the independent risk factors for
MDR-HAI found in this study. Evaluation of the current HAI
control measures as well as adherence to the hospital infec-
tion control guidelines are needed. In addition, current use of
broad-spectrum antibiotics is also an emergent issue that
needs to be investigated and revised in order to decrease the
incidence of MDR-HAI in the PICU.
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